Yasui, H.; Doki, N.; Yan, W.; Imai, K.; Ishida, T.
Determinants of Efficacy and Optimization of Chimeric Antigen Receptor T-Cell Therapy for Treating Multiple Myeloma: Current Status and Future Perspectives. Cells 2026, 15, 380.
https://doi.org/10.3390/cells15040380
AMA Style
Yasui H, Doki N, Yan W, Imai K, Ishida T.
Determinants of Efficacy and Optimization of Chimeric Antigen Receptor T-Cell Therapy for Treating Multiple Myeloma: Current Status and Future Perspectives. Cells. 2026; 15(4):380.
https://doi.org/10.3390/cells15040380
Chicago/Turabian Style
Yasui, Hiroshi, Noriko Doki, Wei Yan, Kohzoh Imai, and Tadao Ishida.
2026. "Determinants of Efficacy and Optimization of Chimeric Antigen Receptor T-Cell Therapy for Treating Multiple Myeloma: Current Status and Future Perspectives" Cells 15, no. 4: 380.
https://doi.org/10.3390/cells15040380
APA Style
Yasui, H., Doki, N., Yan, W., Imai, K., & Ishida, T.
(2026). Determinants of Efficacy and Optimization of Chimeric Antigen Receptor T-Cell Therapy for Treating Multiple Myeloma: Current Status and Future Perspectives. Cells, 15(4), 380.
https://doi.org/10.3390/cells15040380